Abstract
Abstract
Background
Different histological growth patterns (HGP) describing the tumor-to-liver interface have been described in colorectal liver metastases and have been associated with a strong prognostic value. However, HGP of peritoneal metastases (PM) of colorectal cancer (CRC) have not yet been described. Our objective was to determine whether distinct HGP can be identified in PMCRC and to evaluate their potential prognostic value in these patients.
Methods
This retrospective study included 38 patients who underwent curative-intent surgery for PMCRC between July 2012 and March 2019, with PCI≤6, and who had not received preoperative chemotherapy. In each patient, the tumor-to-peritoneum interface was evaluated in the excised peritoneal nodules. The association between HGP and postoperative survival was analyzed by using the Kaplan–Meier method.
Results
Two distinct HGP were identified: a pushing-type (P-HGP), characterized by a fibrous rim separating the PM and peritoneum, and an infiltrating-type (I-HGP), characterized by focal penetration of tumor cells into the surrounding peritoneal lining without a fibrous rim. Fifteen patients had dominant P-HGP, and 23 patients had dominant I-HGP. Patients with dominant P-HGP (>50% tumor-peritoneum interface) had a significantly better DFS (30 months) than those with P-HGP <50% (9 months; p = 0.029). Patients with a P-HGP dominance >60% had better OS (131 months) than those with P-HGP <60% (41 months; p = 0.044).
Conclusions
This is the first description of two distinct, reproducible HGP in PMCRC. The dominant P-HGP is associated with a favorable prognosis in patients with PMCRC, compared with I-HGP, suggesting that this parameter could ultimately represent a new prognostic biomarker.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Kemeny N. Presurgical chemotherapy in patients being considered for liver resection; presurgical chemotherapy in patients being considered for liver resection. Oncologist. 2007;12:825–39. https://doi.org/10.1634/theoncologist.12-7-825.
2. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244(2):254–9. https://doi.org/10.1097/01.sla.0000217629.94941.cf.
3. Barat M, Soyer P, Eveno C, et al. The presence of cardiophrenic angle lymph nodes is not an indicator of peritoneal carcinomatosis from colorectal cancer on MDCT: results of a case-control study. Eur J Surg Oncol. 2016;42(2):266–72. https://doi.org/10.1016/j.ejso.2015.11.011.
4. Surgical Treatment of Colorectal Liver Metastases - Google Books. Accessed January 29, 2021. https://books.google.be/books?hl=en&lr=&id=W1C4oTEnKDAC&oi=fnd&pg=PR4&dq=Muratore+A,+Ribero+D,+Viganos+L+(2011)+Epidemiology+and+natural+history%3B+surgical+treatment+of+colorectal+liver+metastases.+Springer,+Milan,+pp+1-6&ots=LeW9moGYic&sig=PZcObJ8X4-1B7_Gok2C24TpLDt8&redir_esc=y#v=onepage&q&f=false
5. Prader S, Harter P, Grimm C, et al. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer. Published online. 2016. https://doi.org/10.1016/j.ygyno.2016.03.012.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献